Publicacións en colaboración con investigadores/as de Universidade da Coruña (66)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

    Neuromuscular Disorders, Vol. 34, pp. 1-8

  3. Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

    Frontiers in Pharmacology, Vol. 15

  4. Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)

    Trials, Vol. 25, Núm. 1

2023

  1. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  2. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders

    Brain Sciences, Vol. 13, Núm. 2

  3. Liquid Chromatography Fingerprint Analysis of Released Compounds in Plasma Samples of Stroke Patients after Thrombolytic Treatment

    Separations, Vol. 10, Núm. 1

  4. Safety and efficacy of tirofiban in acute ischemic stroke due to tandem lesions undergoing mechanical thrombectomy: A multicenter randomized clinical trial (ATILA) protocol

    European Stroke Journal, Vol. 8, Núm. 1, pp. 380-386

  5. The current situation of Telestroke in Spain

    Neurologia

2022

  1. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1320-1332

  2. Motor Fluctuations Development Is Associated with Non-Mostor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study

    Diagnostics, Vol. 12, Núm. 5

  3. Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

    Brain Sciences, Vol. 12, Núm. 11

2021

  1. Depression is Associated with Impulse-compulsive Behaviors in Parkinson's disease: Impulse-compulsive Behaviors and Depression in PD

    Journal of Affective Disorders, Vol. 280, pp. 77-89

  2. Effectiveness of dimethyl fumarate in real-world clinical practice and strategy to minimize adverse effects and use of healthcare resources

    Patient Preference and Adherence, Vol. 15, pp. 149-158

  3. First Case of Parkinsonian-Pyramidal Syndrome Associated with a TBK1 Mutation

    Movement Disorders

  4. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study

    Parkinsonism and Related Disorders, Vol. 88, pp. 68-75

  5. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158

  6. Management of Parkinson's disease and other movement disorders in women of childbearing age: Part 2

    Neurologia, Vol. 36, Núm. 2, pp. 159-168

  7. Mood in Parkinson's disease: From early- to late-stage disease

    International journal of geriatric psychiatry, Vol. 36, Núm. 5, pp. 627-646

  8. Palliative care management in patients with Parkinson's disease and other movement disorders. National survey to neurologists

    Neurologia